Publicaciones en las que colabora con Zoraida Verde Rello (26)

2022

  1. Physical Condition and Risk of Hospitalization and Polypharmacy in Older Adults

    Rejuvenation Research, Vol. 25, Núm. 4, pp. 200-206

2019

  1. Association of HTR2A-1438G/A Genetic Polymorphism With Smoking and Chronic Obstructive Pulmonary Disease

    Archivos de Bronconeumologia, Vol. 55, Núm. 3, pp. 128-133

  2. Physical performance, plasma S-klotho, and all-cause mortality in elderly dialysis patients: A prospective cohort study

    Experimental Gerontology, Vol. 122, pp. 123-128

2017

  1. A Paradox: α-Klotho Levels and Smoking Intensity

    Lung, Vol. 195, Núm. 1, pp. 53-57

  2. Telomere length in elite athletes

    International Journal of Sports Physiology and Performance, Vol. 12, Núm. 7, pp. 994-996

2016

  1. Effect of genetic polymorphisms and long-term tobacco exposure on the risk of breast cancer

    International Journal of Molecular Sciences, Vol. 17, Núm. 10

  2. The effect of polymorphisms in DNA repair genes and carcinogen metabolizers on leukocyte telomere length: A cohort of healthy Spanish smokers

    Nicotine and Tobacco Research, Vol. 18, Núm. 4, pp. 447-452

2015

  1. Are SNP-Smoking association studies needed in controls? DNA repair gene polymorphisms and smoking intensity

    PLoS ONE, Vol. 10, Núm. 5

  2. Effects of cigarette smoking and nicotine metabolite ratio on leukocyte telomere length.

    Environmental Research, Vol. 140, pp. 488-494

  3. Physical-capacity-related genetic polymorphisms in children with cystic fibrosis

    Pediatric Exercise Science, Vol. 27, Núm. 1, pp. 102-112

2014

  1. ACTN3 R577X polymorphism and explosive leg-muscle power in elite basketball players

    International Journal of Sports Physiology and Performance, Vol. 9, Núm. 2, pp. 226-232

  2. ApoE gene and exceptional longevity: Insights from three independent cohorts

    Experimental Gerontology, Vol. 53, pp. 16-23

  3. Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6 ?

    Pharmacopsychiatry, Vol. 47, Núm. 1, pp. 33-36

2013

  1. Genetics of the tobacco smoking

    Medicina Clinica, Vol. 140, Núm. 2, pp. 66-67

2012

  1. Acyl coenzyme A synthetase long-chain 1 (ACSL1) gene polymorphism (rs6552828) and elite endurance athletic status: A replication study

    PLoS ONE, Vol. 7, Núm. 7

  2. Polimorfismos genéticos implicados en la dependencia a nicotina, efectividad de los tratamientos de deshabituación tabáquica y desarrollo de patologías derivadas del consumo de tabaco

    Polimorfismos genéticos implicados en la dependencia a nicotina, efectividad de los tratamientos de deshabituación tabáquica y desarrollo de patologías derivadas del consumo de tabaco

2011

  1. 'Smoking Genes': A genetic association study

    PLoS ONE, Vol. 6, Núm. 10

  2. ACTN3 R577X polymorphism does not influence explosive leg muscle power in elite volleyball players

    Scandinavian Journal of Medicine and Science in Sports, Vol. 21, Núm. 6

2010

  1. A novel, single algorithm approach to predict acenocoumarol dose based on CYP2C9 and VKORC1 allele variants

    PLoS ONE, Vol. 5, Núm. 6

  2. ACE and ACTN3 genes and muscle phenotypes in nonagenarians

    International Journal of Sports Medicine, Vol. 31, Núm. 4, pp. 221-224